Atlas Trials

A Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of MegaLT Injection for Treating Refractory Thrombocytopenia Following Radiotherapy, Chemotherapy, or Transplantation.

Clinical trial NCT06534255 · COMPLETED

Trial details

NCT number
NCT06534255
Sponsor
Anhui Provincial Hospital
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Refractory Thrombocytopenia
Start date
2024-12-04
Primary completion
2025-06-19
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.